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Major scientific flaws such as reporting and publication biases are well documented,
even though acknowledgment of their importance appears to be lacking in various
psychological and medical fields. Subtle and less obvious biases including selective
reviews of the literature and empirically unsupported conclusions and recommendations
have received even less attention. Using the literature on the association between
transition to menopause, hormones and the onset of depression as a guiding example,
I outline how such scientific fallacies undermine the validity of neuroendocrinological
research. It is shown that in contrast to prominent claims, first, most prospective studies
do not support the notion that the menopausal transition relates to increased risk for
depression, second, that associations between hormone levels and depression are
largely inconsistent and irreproducible, and, third, that the evidence for the efficacy
of hormone therapy for the treatment of depression is very weak and at best
inconclusive. I conclude that a direct and uniform association between female sex
hormones and depression is clearly not supported by the literature and that more
attention should be paid to the manifold scientific biases that undermine the validity
of findings in psychological and medical research, with a specific focus on the behavioral
neurosciences.
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BACKGROUND
Based on extensive theoretical considerations, Ioannidis (2005a) drew the bold conclusion
that, in biomedicine, ‘‘most published research findings are false’’. Original studies subjecting
psychological and medical research to close scrutiny have indeed provided ample evidence that
many, and sometimes even a majority, of published findings are irreproducible, false positive, or
severely inflated (Ioannidis, 2005b; Turner et al., 2008; Munafo et al., 2009; Bakker et al., 2012;
Begley and Ellis, 2012; Open Science Collaboration, 2015; Müller et al., 2017); for reviews see
(Nosek et al., 2012; Macleod et al., 2014; Naci and Ioannidis, 2015). More specifically, Open Science
Collaboration (2015) tried to replicate 100 original studies published in 2008 in three leading
psychology journals. While 97% of original studies had a significant result (i.e., p< 0.05), only 36%
of the replication studies revealed a significant result, even though they all had high statistical power.
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Moreover, in the original studies the average effect size was
r = 0.403 (SD = 0.188), whereas in the replication studies it was
only r = 0.197 (SD = 0.257), suggesting that the evidence for
the original findings is rather weak (Open Science Collaboration,
2015). Very recently, Müller et al. (2017) meta-analyzed
neuroimaging studies in persons with unipolar depression
conducted between 1997 and 2015 and found not a single
functional neuro-pattern that replicated consistently across
studies, suggesting that the grand majority of published findings
are irreproducible or false-positives. Finally, Contopoulos-
Ioannidis et al. (2003) identified a total of 101 articles published
between 1979 and 1983 in six leading biomedical journals,
which clearly stated that the technology studied had novel
therapeutic or preventive promises. However, most findings
turned out to be false-positives or gross overestimations; by
October 2002, only 27 of the promising technologies had resulted
in at least one published randomized trial, five articles resulted
in interventions with clinical licence, but only one finding
lead to the development of an intervention that has been used
extensively for the licensed indications (Contopoulos-Ioannidis
et al., 2003).
In psychology/psychiatry the rate of positive findings
(i.e., p < 0.05) is currently around 92% (Fanelli, 2010). Because
92% of all published results cannot possibly be true-positives
given the average sample size and statistical power in published
research, obviously strong and systematic biases are taking effect
(Bakker et al., 2012; Button et al., 2013). There are various reasons
for this excess significance bias, including foremost, reporting
and publication biases (Ferguson and Heene, 2012; Glasziou
et al., 2014; Ioannidis et al., 2014b) as well as methodological
biases such as statistical misconduct and questionable research
practices (Simmons et al., 2011; John et al., 2012; Ioannidis
et al., 2014a). Because many conflicting results and negative
findings are not objectively reported or published, the scientific
literature is systematically biased towards spectacular positive
findings (Young et al., 2008; Nosek et al., 2012), which leads
to inflated meta-analytic estimates of effect sizes (Cuijpers
et al., 2010; Ioannidis, 2011; Bakker et al., 2012). As a
result, effectiveness of pharmaceutical drugs and impact of
neurobiological and psychological findings are systematically
overestimated (Ferguson and Heene, 2012; Button et al., 2013;
Turner, 2013).
However, there are also subtle and less obvious fallacies.
Sometimes conflicting results such as negative findings are
sufficiently published, but these are simply not adequately
acknowledged and considered (Jannot et al., 2013; Chalmers
et al., 2014). That is, many researchers selectively review the
literature and come to rather arbitrary conclusions that are not
unequivocally supported by the published evidence (Ioannidis
et al., 2007; Tatsioni et al., 2007; Saraga and Stiefel, 2011).
Using the literature on the association between transition to
menopause, hormonal changes and the onset of depression as a
guiding example, I will thoroughly outline that many prominent
claims do not hold up to close scrutiny and are therefore grossly
exaggerated or false. I will ponder my arguments by testing two
prevalent claims, the first being that the transition to menopause
increases the risk for depression and the second that changing
hormone levels directly and uniformly increase the risk for
depression.
FIRST CLAIM: THE TRANSITION TO
MENOPAUSE INCREASES THE RISK FOR
DEPRESSION
That claim has been put forward by various authors of
original studies (e.g., Bromberger et al., 2011; Joffe et al.,
2016) and narrative reviews (e.g., Freeman, 2010; Soares,
2010). For instance, Bromberger et al. (2011) stressed that ‘‘we
have moved from the ‘‘belief’’ that women were particularly
susceptible to depression after the menopausal transition to
the current empirically supported conclusion that middle-aged
women are at a greater risk for depression during the
transition than before [references]’’ (p. 1879). In addition,
Soares (2010) stated that ‘‘Unlike cross-sectional studies, most
prospective studies [references] have systematically confirmed
the menopausal transition as a period of heightened risk for
development of depressive symptoms and/or depression’’ (p. 2).
Both strengthen their statement by citing various prospective
observational studies that ostensibly confirmed the association
between depression and transition to menopause. However,
that view does not withstand close scrutiny and has been
challenged by various contradictory findings (Judd et al.,
2012; Rössler et al., 2016). First of all, that claim misses
that most prospective studies did actually NOT report an
association (Vesco et al., 2007; Rössler et al., 2016), so here
many researchers are producing a severe confirmation bias
by selectively reviewing a minority of studies with positive
results that are not representative of the broader literature
(Ioannidis et al., 2007; Tatsioni et al., 2007; Chalmers et al.,
2014). Of concern is also the substantial content overlap
between depression and menopause symptoms such as sleep
disturbance, fatigue and irritability (Judd et al., 2012; Davis
et al., 2015). Part of the covariance between menopause and
depression symptoms is therefore tautological, which artificially
inflates the strength of association. This could at least in part
explain why some studies relying of self-report inventories of
depression find a significant association anyway. In addition,
various prospective studies that did report a positive association
appear to be systematically biased due to the inadequate statistical
procedure of dichotomization of a continuous measure of
depression. As demonstrated by Rössler et al. (2016), when a
continuous measure of depression is artificially dichotomized
into categories of present vs. absent based on arbitrary cut-offs,
false-positive associations with menopause stages can emerge.
That the dichotomization of continuous variables conveys
severe bias is widely acknowledged in the methodological
literature (Ragland, 1992; MacCallum et al., 2002; Royston
et al., 2006). Unfortunately, that ill-advised practice is still
very prevalent in psychological and medical research. Rössler
et al. (2016) name further biases in highly cited reports of
positive associations between menopause transition and the
onset of depression. These comprise among others overfitting
and multiple adjustments in multivariable regression models,
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which can also produce inflated or false-positive associations
(Babyak, 2004; Simmons et al., 2011).
In conclusion, firstly, most prospective studies failed to
provide support for a positive association between the transition
to menopause and the occurrence of depression (Vesco et al.,
2007; Rössler et al., 2016). Unfortunately, when looking at
citation patterns one will easily recognize that the studies with
positive findings receive much more attention than studies with
negative findings (Kjaergard and Gluud, 2002; Jannot et al., 2013;
Glasziou et al., 2014). For example, the negative findings from
Avis et al. (1994) and Kaufert et al. (1992) received 499 and
380 citations (as of October 2016), whereas themuchmore recent
positive findings by Cohen et al. (2006) and Freeman et al. (2006)
received already 562 and 538 citations. Second, some studies that
did report a positive association applied problematic statistical
procedures indicating that data were possibly ‘‘tortured until
they confess’’ (Wagenmakers et al., 2012) to obtain statistically
significant associations at p < 0.05 (Simmons et al., 2011; John
et al., 2012; Ioannidis et al., 2014a). That phenomenon is also
well documented as p-hacking and referred to journals’ and
researcher’s aversion towards negative findings (Young et al.,
2008; Ferguson and Heene, 2012; Nosek et al., 2012).
SECOND CLAIM: HORMONE LEVELS
DIRECTLY INFLUENCE DEPRESSIVE
SYMPTOMS
Due to a selective reference to positive associations between
the transition to menopause and depression (see above), it was
concluded that the hormonal changes during that period may
cause depression. As a result, hormone replacement therapy has
been proposed as a potent first-line treatment for depression
in peri-menopausal women (Riecher-Rössler and de Geyter,
2007; Georgakis et al., 2016). As above, that claim is not
sufficiently supported by the literature. First of all, the association
between hormone levels and depression during the transition to
menopause is unclear, that is, positive associations are merely
anecdotal and have not been replicated thus far (see reviews
by Freeman, 2010; Vivian-Taylor and Hickey, 2014). So, once
rapidly increasing FSH relates to lower risk of depression
(Freeman et al., 2004) and once to higher risk of depression
(Ryan et al., 2009), then again it is testosterone (Bromberger
et al., 2010) and according to another study it is the fluctuating
estradiol (Freeman et al., 2006) that causes depression.Moreover,
as we would expect from a true null association, it comes
as no surprise that some studies did not find any association
between hormone levels and depression at all (Woods et al.,
2008; Bromberger et al., 2011). In accordance, results from
randomized clinical trials testing the efficacy of hormone
therapy for depressive symptoms in menopausal women are
also inconsistent (Soares et al., 2001; Morrison et al., 2004;
Joffe et al., 2011) and provide overall only weak evidence in
support of hormone therapy for depressed peri-menopausal
but not post-menopausal women (see systematic review by
Rubinow et al., 2015). However, due to substantial reporting
and publication biases in the evaluation of drug trials (Turner,
2013; Naci and Ioannidis, 2015), these suggestions must be taken
with reservation. Also, in initially non-depressed women who
make the transition to menopause, hormone therapy has no
preventive value (Rubinow et al., 2015). Recently, Georgakis
et al. (2016) showed in a comprehensive meta-analysis that in
women who naturally enter menopause (n = 67434), higher age
at menopause was associated with a marginally smaller risk of
depression (OR = 0.98 for a 2-year increment, p < 0.05). They
supposed that this association was due to estrogen exposure
and concluded that estrogen-based therapies could be useful to
prevent depression in womenwho naturally enter themenopause
before population average, even though the systematic review by
Rubinow et al. (2015) concluded that hormone therapy has no
preventive value. In a commentary on Georgakis et al. (2016),
Hengartner (2016) transformed that odds ratio effect size into
the number needed to treat (NNT), which is a convenient
measure to quantify the effectiveness of medical treatments
(Cook and Sackett, 1995). He showed that the NNT was 500,
suggesting that 500 women would need to undergo continuous
estrogen substitution for 2 years in order to prevent depression
in only one woman (Hengartner, 2016). Of course, such a
treatment is ineffective and no option to prevent depression
in women making the transition to menopause. Unfortunately,
misleading and empirically unsupported conclusions are quite
common in medical research (Ioannidis et al., 2007; Saraga
and Stiefel, 2011). In addition, another very prevalent scientific
fallacy in contemporary psychological and medical research is
the confusion of statistical significance with practical significance
(Kirk, 1996). When the sample size is large enough (say
n > 10000), even negligibly small deviations from the null that
bear absolutely no practical implications will become statistically
significant (Cohen, 1994; Hengartner, 2016).
In conclusion, a critical examination of the literature does
not support the view that sex hormone levels uniformly relate
to depression. A systematic review of the literature indicates
that most published findings are anecdotal, irreproducible
and inconsistent, especially in the behavioral neurosciences
(Ioannidis, 2011; Rosmalen and Oldehinkel, 2011; Ioannidis
et al., 2014b; Sundström Poromaa and Gingnell, 2014; Müller
et al., 2017). Nevertheless, many researchers tend to selectively
review the literature (Tatsioni et al., 2007; Jannot et al.,
2013) and to uncritically draw conclusions that are not
sufficiently supported by the literature (Ioannidis et al., 2007;
Saraga and Stiefel, 2011; Chalmers et al., 2014). Premature
treatment recommendations can expose thousands of patients
to treatments that are largely ineffective or that may cause
more harm than good (Naci and Ioannidis, 2015). In this
respect it is also necessary to evaluate the net benefit of a given
therapy. Too often researchers equate statistical significance
with clinical significance (Hengartner, 2016), ignoring that
statistical significance does not allow to make inferences on the
effectiveness of a given treatment (Cohen, 1994; Kirk, 1996).
CONCLUDING REMARKS
By now it is increasingly documented that some psychological
and medical science is systematically flawed (Ioannidis, 2005a;
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Ferguson and Heene, 2012; Pashler and Harris, 2012; Macleod
et al., 2014). However, both researchers and journals have an
aversion towards null results, because they neither boost a
researcher’s career nor a journal’s reputation (Young et al., 2008;
Nosek et al., 2012).Major scientific fallacies such as reporting and
publication biases cause a systematic overestimation of reported
effect sizes to the point that many associations in the scientific
literature are eventually marginally small or false-positives
(Bakker et al., 2012; Ferguson and Heene, 2012; Ioannidis
et al., 2014b; Naci and Ioannidis, 2015). However, reporting
and publication biases are only the tip of the iceberg. Using
the association between transition to menopause, hormones and
depression as a guiding example, I demonstrated that, first, the
scientific literature is often selectively reviewed and synthesized
(Tatsioni et al., 2007) and second, that unsupported conclusions
and treatment recommendations are readily made (Saraga and
Stiefel, 2011). Specifically, in contrast to prominent claims that an
increased risk for depression during the transition to menopause
is clearly confirmed by the literature (Soares, 2010; Bromberger
et al., 2011), a critical examination of the literature reveals that
most prospective studies did not show a meaningful association
(Vesco et al., 2007; Rössler et al., 2016). As the transition
to menopause is a critical life event accompanied by major
psychosocial changes, the most promising explanation is that
these psychosocial risk factors may predispose vulnerable women
to depression, but not the hormonal changes per se (Kaufert
et al., 1992; Nelson, 2008; Rössler et al., 2016). In line with that
notion it has been shown that an association between hormonal
changes during the menopausal transition and depression is
largely inconsistent (compare: Freeman et al., 2004; Woods
et al., 2008; Ryan et al., 2009; Bromberger et al., 2010) and that
the efficacy of hormone therapy to treat depression is at best
inconclusive (Nelson, 2008; Rubinow et al., 2015). Therefore,
recommending estrogen as a useful (preventive) treatment for
depression in peri-menopausal women appears misguided and
premature.
I strongly believe that hormones are crucial for affect
and behavior. However, their effect on psychopathology is
certainly not direct and uniform, otherwise research would have
shown it. It is therefore supposed that hormones modulate
complex psychobiological mechanisms such as the stress
response system, and that these, further modulated through
even more psychobiological factors, impact on psychopathology
(Zahn-Waxler et al., 2008; Naninck et al., 2011; Handa and
Weiser, 2014). However, research into complex neurobiological
systems is just at its beginning. As long as the neurosciences
are so fundamentally hampered by manifold methodological
biases, including notoriously underpowered samples, opaque
experimental designs, almost unrestricted flexibility in data
analysis and flawed statistical methods (e.g., Kriegeskorte et al.,
2009; Carp, 2012; Button et al., 2013; Eklund et al., 2016),
increased consistency and reproducibility of neurobiological
research findings will not be readily achieved. A particularly
striking example was provided by the senior authors of
the Tracking Adolescents’ Individual Lives Survey (TRAILS;
Rosmalen and Oldehinkel, 2011). This large multisite project was
designed to focus on the effects of cortisol on psychopathology.
Rosmalen and Oldehinkel (2011) self-critically admit, that
when they soon realized that the initial cross-sectional analyses
yielded mainly null results or negligibly weak associations,
the principal investigators started to test manipulations and
different definitions of predictor and outcome variables; they
arbitrarily included varying sets of potential confounders,
and they used alternative statistical procedures in order to
obtain statistically significant associations. The result of these
inappropriate data manipulations (see Simmons et al., 2011)
is that they achieved to publish spectacular positive findings
in the leading journals. However, ultimately these confusing
findings were highly inconsistent and most likely irreproducible
false-positives that did not advance our knowledge in this
field (Rosmalen and Oldehinkel, 2011). Looking at other
hot topics in the behavioral neurosciences (e.g., Sundström
Poromaa and Gingnell, 2014), one will easily recognize that
this issue is the rule rather than the exception. It will
therefore presumably take some time until we know how
sex hormones and complex neurobiological systems influence
psychopathology. In the meantime we are best advised to
abstain from oversimplified and premature conclusions and
instead to pay more attention to scientific and methodological
biases.
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